DEep LearnIng-based QuaNtification of Epicardial Adipose Tissue Predicts MACE in Patients Undergoing Stress CMR
Overview
Authors
Affiliations
Background And Aims: This study investigated the additional prognostic value of epicardial adipose tissue (EAT) volume for major adverse cardiovascular events (MACE) in patients undergoing stress cardiac magnetic resonance (CMR) imaging.
Methods: 730 consecutive patients [mean age: 63 ± 10 years; 616 men] who underwent stress CMR for known or suspected coronary artery disease were randomly divided into derivation (n = 365) and validation (n = 365) cohorts. MACE was defined as non-fatal myocardial infarction and cardiac deaths. A deep learning algorithm was developed and trained to quantify EAT volume from CMR. EAT volume was adjusted for height (EAT volume index). A composite CMR-based risk score by Cox analysis of the risk of MACE was created.
Results: In the derivation cohort, 32 patients (8.7 %) developed MACE during a follow-up of 2103 days. Left ventricular ejection fraction (LVEF) < 35 % (HR 4.407 [95 % CI 1.903-10.202]; p<0.001), stress perfusion defect (HR 3.550 [95 % CI 1.765-7.138]; p<0.001), late gadolinium enhancement (LGE) (HR 4.428 [95%CI 1.822-10.759]; p = 0.001) and EAT volume index (HR 1.082 [95 % CI 1.045-1.120]; p<0.001) were independent predictors of MACE. In a multivariate Cox regression analysis, adding EAT volume index to a composite risk score including LVEF, stress perfusion defect and LGE provided additional value in MACE prediction, with a net reclassification improvement of 0.683 (95%CI, 0.336-1.03; p<0.001). The combined evaluation of risk score and EAT volume index showed a higher Harrel C statistic as compared to risk score (0.85 vs. 0.76; p<0.001) and EAT volume index alone (0.85 vs.0.74; p<0.001). These findings were confirmed in the validation cohort.
Conclusions: In patients with clinically indicated stress CMR, fully automated EAT volume measured by deep learning can provide additional prognostic information on top of standard clinical and imaging parameters.
Hara T, Sata M Front Physiol. 2025; 15():1522471.
PMID: 39835204 PMC: 11744021. DOI: 10.3389/fphys.2024.1522471.
Novel Insights into Non-Invasive Diagnostic Techniques for Cardiac Amyloidosis: A Critical Review.
Dicorato M, Basile P, Muscogiuri G, Carella M, Naccarati M, Dentamaro I Diagnostics (Basel). 2024; 14(19).
PMID: 39410653 PMC: 11475987. DOI: 10.3390/diagnostics14192249.
Dimitriadis K, Pyrpyris N, Theofilis P, Mantzouranis E, Beneki E, Kostakis P Diagnostics (Basel). 2024; 14(15).
PMID: 39125547 PMC: 11311283. DOI: 10.3390/diagnostics14151671.
Napoli G, Mushtaq S, Basile P, Carella M, De Feo D, Latorre M J Clin Med. 2024; 13(14).
PMID: 39064316 PMC: 11278082. DOI: 10.3390/jcm13144277.